Abstract
This scientific commentary refers to ‘Clinical markers of disease progression in the prodromal to overt alpha-synucleinopathy continuum’, by Roascio et al. (https://doi.org/10.1093/brain/awag193).
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureJiří Nepožitek, Kristína Kulcsárová, Petr Dušek
Abstract
Authors
Institutions
Provenance
crossref
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Clinical markers of disease progression in the prodromal to overt alpha-synucleinopathy continuum
2026
AD course map charts Alzheimer's disease progression
10.1038/s41598-021-87434-1 · 2021
Prodromal dementia with Lewy bodies in REM sleep behavior disorder: A multicenter study
10.1002/alz.13386 · 2024
Relations of non-motor symptoms and dopamine transporter binding in REM sleep behavior disorder
10.1038/s41598-019-51710-y · 2019
Cortical macro- and microstructural changes in isolated rapid eye movement sleep behavior disorder
10.1038/s41531-025-01058-0 · 2025
Defining Parkinson's disease: Past and future
10.3233/jpd-230411 · 2024
α-Synuclein seed amplification assay amplification parameters and the risk of progression in prodromal Parkinson disease
10.1212/wnl.0000000000210279 · 2025
Speech biomarkers from smartphone calls track progression in REM sleep behavior disorder and Parkinson's disease
10.1002/ana.78140 · 2026
Progression of clinical markers in prodromal Parkinson's disease and dementia with Lewy bodies: A multicentre study
10.1093/brain/awad072 · 2023
Confidence 100%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
openalex
Confidence 95%
datacite
Confidence 0%
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: A multicentre study
10.1093/brain/awz030 · 2019
No additional external references are available.